Table 1. Studies serially analyzing recanalization and reperfusion in ischemic stroke patients.
Type of treatment | Time to initiation of treatment | Tool for assessing reperfusion | Tool for assessing recanalization | Time of evaluation | Number of patients with successful recanalization | Percentage (95% CI) of patients without reperfusion | |
---|---|---|---|---|---|---|---|
Baird et al90 | IA SK | 4 to 24 hours | SPECT | CA | 24 to 48 hours | 4 | 25% (13–78%) |
Yasaka et al91 | IV SK or placebo | <4 hours | SPECT | TCD | 24 hours | 8 | 50% (17–83%) |
Khatri et al92 | IV+IA tPA | <3 hours | CA | CA | Completion of angiographya | 43 | 23% (12–39) |
Tomsick et al93 | IV tPA or IV+IA tPA | <3 hours | CA | CA | Completion of angiographya | 26 | 19% (7–40%) |
Albers et al94 | IV tPA | 3 to 6 hours | MRP | MRA | 3 to 6 hours after tPAb | 19 | 21% (7–46%) |
De Silva et al22 | IV tPA or placebo | 3 to 6 hours | MRP | MRA | 3 to 5 days | 13 | 31% (10–61%) |
Soares et al21 | IV tPA or IA MT or IV tPA+IA MT or standard treatment | <5 hours | CTP | CTA | 24 hours | 13 | 38% (15–68%) |
Overall | 26% (19–35%) |
CA, conventional angiography; CI, confidence interval; CTA, computed tomography angiography; CTP, computed tomography perfusion; IA, intraarterial; IV, intravenous; MRA, magnetic resonance imaging angiography; MRP, magnetic resonance imaging perfusion; MT, mechanical thrombolysis; SK, streptokinase; SPECT, single-photon emission computed tomography; TCD, transcranial Doppler ultrasonography; tPA, tissue plasminogen activator.
Intravenous tPA had to be started within 3 hours of symptom onset; this was followed with initiation of intraarterial tPA (with or without intraarterial sonography) infusion that lasted for a maximum of 2 hours.
The median door to needle time was 328 minutes in the study.